 Home > Active Ingredient News > Antitumor Therapy > Cancers: Biomarkers for immunotherapy of advanced gastroesophageal cancer

Cancers: Biomarkers for immunotherapy of advanced gastroesophageal cancer

 Last Update: 2021-05-31
 Source: Internet
 Author: User

Tags

anti biotin antibody

100 markers

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The current prognosis of advanced gastroesophageal cancer (GEC) is very poor, and the treatment options available are limited.

immunity

At present, several immunotherapy biomarkers have been verified to be used in the clinical treatment of GEC, including the expression of programmed death ligand-1 (PD-L1), and broad-spectrum biomarkers independent of tumor type, such as mismatches Repair or microsatellite instability (MMR/MSI) and tumor mutational burden (TMB).

In addition to tumor type-independent markers MSI and TMB, the only validated predictive biomarker for immunotherapy in GEC is PD-L1 CPS.

In the future, it is important to determine the role of immunotherapy biomarkers in combination therapy, especially when immunotherapy is used together with therapies with other mechanisms of action, whether a biomarker can maintain its predictive power.

Original source:

Robin Park, et al.

ncbi.
nlm.
nih.
gov/33916348/" target="_blank" rel="noopener">Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer : MSI and Beyond

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gefitinib

CAS No.: 184475-35-2

Pharmacy Grade

$1/MT FOB

High quality Sunitinib CAS NO 557795-19-4 Orange solid powder 99% API for antitumor

CAS No.: 557795-19-4

Pharmacy Grade

$4.1-4.2/G FOB

Epirubicin

CAS No.: 56420-45-2

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.